1. DSpace at My University
  2. E-Journal
  3. Teknologi Bank Darah
  4. Jurnal Internasional
  5. Journal of Microbiology, Immunology and Infection
  6. VOL 55 NO 2 2022
Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9200
Title: Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan
Authors: Cheng, Chao-Neng
Li, Sin-Syue
Yeh, Yun-Hsuan
Shen, Ching-Fen
-Shiuh Chen, Jiann
Keywords: Children;
Cytomegalovirus;
Hematopoietic stem cell transplantation;
Letermovir;
Prophylaxis
Issue Date: 1-Apr-2022
Publisher: Elsevier Taiwan LLC
Abstract: Abstract From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted.
URI: http://localhost:8080/xmlui/handle/123456789/9200
ISSN: 1684-1182
Appears in Collections:VOL 55 NO 2 2022

Files in This Item:
File Description SizeFormat 
323-327.pdf668.2 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.